CD28 and idiopathic pulmonary fibrosis: Previous studies reported that peripheral blood T cells in patients with well-established IPF present a surface signature characterized by the loss of co-stimulatory molecules, specifically CD28 [10]; our results at diagnosis (hence, the earlier stages of disease) agree with these previous findings.